![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, March 29, 2011 6:26:43 PM
Between 3/3/2011 and 3/29/2011 - 44.21% - 6,529,653 shares short / total daily vol. 14,768,626
3/3/2011 - 55.76% - 166,000 shares short / total daily vol. 297,695
3/4/2011 - 26.24% - 29,350 shares short / total daily vol. 111,853
3/7/2011 - 13.84% - 95,750 shares short / total daily vol. 691,650
3/8/2011 - 27.10% - 100,000 shares short / total daily vol. 369,000
3/9/2011 - 42.84% - 147,400 shares short / total daily vol. 344,100
3/10/2011 - 24.46% - 96,300 shares short / total daily vol. 393,740
3/11/2011 - 38.79% - 60,200 shares short / total daily vol. 155,200
3/14/2011 - 33.90% - 50,500 shares short / total daily vol. 148,966
3/15/2011 - 48.32% - 424,397 shares short / total daily vol. 878,394
3/16/2011 - 59.31% - 771,861 shares short / total daily vol. 1,301,361
3/17/2011 - 50.63% - 650,000 shares short / total daily vol. 1,283,778
3/18/2011 - 58.92% - 306,000 shares short / total daily vol. 519,332
3/21/2011 - 57.95% - 75,200 shares short / total daily vol. 129,770
3/22/2011 - 67.53% - 390,000 shares short / total daily vol. 577,500
3/23/2011 - 67.38% - 237,500 shares short / total daily vol. 352,500
3/24/2011 - 17.23% - 124,780 shares short / total daily vol. 723,996
3/25/2011 - 89.35% - 1,443,615 shares short / total daily vol. 1,615,741
3/28/2011 - 23.07% - 957,800 shares short / total daily vol. 4,152,600
3/29/2011 - 55.86% - 403,000 shares short / total daily vol. 721,450
ORF Section
regsho.finra.org/regsho-Index.html
Disclaimer
*Exclusive of Form-T trades. Using data reported to the regulator, FINRA, over brokerage platforms (i.e. E*Trade)
the trend is your friend
Recent CLRB News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 10:45:19 AM
- Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update • GlobeNewswire Inc. • 08/13/2024 10:40:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 09:00:47 PM
- UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024 • GlobeNewswire Inc. • 08/08/2024 09:15:14 PM
- Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024 • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/24/2024 04:15:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 10:45:24 AM
- Cellectar Biosciences’ Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom’s Macroglobulinemia Pivotal Study with 78% of Major Response Patients Remaining Progression Free at 18 Months • GlobeNewswire Inc. • 07/23/2024 10:40:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 10:45:16 AM
- Cellectar Biosciences Announces Exercise of Tranche B Warrants and Purchase of New Warrants for Approximately $19.4 million with the Potential to Raise Up to an Additional $73.3 Million • GlobeNewswire Inc. • 07/22/2024 10:40:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 07/11/2024 09:37:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 09:15:21 PM
- Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape • GlobeNewswire Inc. • 06/27/2024 10:40:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:04:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:04:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:03:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:02:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:01:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:01:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 09:04:30 PM
- Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides • GlobeNewswire Inc. • 05/29/2024 10:40:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/24/2024 08:46:56 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 05/16/2024 10:05:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 10:45:17 AM
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results • SNWV • Aug 13, 2024 7:11 AM
Kona Gold Beverages, Inc. Nears Completion of Reverse Merger with New Candidate • KGKG • Aug 12, 2024 10:00 AM
Maybacks Global Entertainment and DigiTrax Entertainment Sign Agreement to Broadcast "Karaoke Cloud" on iDreamCTV • AHRO • Aug 12, 2024 8:45 AM
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients • HLYK • Aug 12, 2024 8:00 AM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM